IGHE and Eczematoid dermatitis: Evidence from randomized controlled trials (RCTs) of prenatal supplementation with ω-3 LCPUFA report consistent protective effects on the risk of IgE mediated eczema [14, 15] and sensitization to egg [14–17] at 1 year of age.